<DOC>
	<DOCNO>NCT00090259</DOCNO>
	<brief_summary>This multicenter study evaluate potential decrease hospitalization event time event increase longevity patient symptomatic congestive heart failure intolerant first-line medication heart failure . This study evaluate high dos investigational drug give daily superior low dose investigational drug give daily .</brief_summary>
	<brief_title>Study Evaluate Potential Decrease Hospitalization Events , Time Between Events , Increasing Longevity Patients With Symptomatic Heart Failure ( 0954-948 )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Symptomatic heart failure know recently diagnose intolerance treatment firstline medication heart failure May may receive alternative and/or additional drug treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>